US Patent 11912778 Methods of engineering transferrin receptor binding polypeptides
Patent 11912778 was granted and assigned to Denali Therapeutics on February, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11912778 Methods of engineering transferrin receptor binding polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
